Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoladex and Arimidex vs Tamoxifen in Premenopausal Early Breast Cancer
NCT01352091Phase 3Unknown
- Sponsor
- Fudan University
- Start
- May 2008
- Primary completion
- May 2015
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin, anastrozole in breast cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
goserelinanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01352091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352091.